Clinical Trials Directory

Trials / Conditions / Respiratory Syncytial Virus Prevention

Respiratory Syncytial Virus Prevention

4 registered clinical trials studyying Respiratory Syncytial Virus Prevention.

StatusTrialSponsorPhase
CompletedFirst Year Impact of Nirsevimab on Paediatric Respiratory Syncytial Virus Infection and Hospitalisations in th
NCT07177508
Nicola Irwin—
TerminatedA Study of Adenovirus Serotype 26.Respiratory Syncytial Virus.Pre-Fusion F (Ad26.RSV.preF)-Based Vaccine for P
NCT05242432
Janssen Pharmaceutical K.K.Phase 3
CompletedA Study of an Ad26.RSV.PreF-based Regimen at the End of Shelf-life in Adults Aged 60 to 75 Years
NCT05101486
Janssen Vaccines & Prevention B.V.Phase 3
CompletedA Study Evaluating the Immunogenicity of Different Clinical Trial Materials of Ad26.RSV.preF- Based Vaccine in
NCT05083585
Janssen Vaccines & Prevention B.V.Phase 3